Best mRNA / LNP CDMOs by Signal Score

← All mRNA/LNP CDMOs Best Clean FDA History Commercial Scale
Region: USA Europe Asia
10
CDMOs tracked
10
Fully scored
6
With FDA records
12
FDA inspections
72
EMA/MHRA GMP certs

mRNA and lipid nanoparticle (LNP) manufacturing scaled rapidly after COVID-19 vaccines and now supports therapeutics across rare disease, oncology, and infectious disease. The platform pairs IVT mRNA synthesis with LNP formulation — two distinct capability sets.

Choosing an mRNA/LNP CDMO depends on IVT scale, template strategy (linearized plasmid vs PCR), LNP formulation and microfluidics, and cold-chain handling. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.

FDA inspection outcomes across these CDMOs: 6 NAI (no action), 6 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: Germany (18), Denmark (17), Ireland (13), UNITED KINGDOM (13), United States (10).

Last updated 2026-08-21. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

# CDMO Signal Score Quality FDA · GMP Capacity Programs
1
PC
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
 91.5 100.0 4 insp · 17 GMP — 363 programs
2
BNT
BioNTech (Mfg Services)
Mainz, DE · Marburg, DE
 84.8 100.0 0 insp · 8 GMP — 27 programs
3
MR
Moderna (Contract Mfg)
Norwood, MA
 81.8 100.0 2 insp · 4 GMP — 10 programs
4
MK
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
 81.8 98.6 2 insp · 2 GMP — 22 programs
5
Lonza
Basel, Switzerland
 78.2 95.1 2 insp · 8 GMP — 1 programs
6
CVC
CureVac (CDMO Services)
Tubingen, DE
 75.3 100.0 0 insp · 7 GMP — 4 programs
7
NR
National Resilience
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
 73.4 97.7 1 insp · 0 GMP Available 9 programs
8
RP
ReciBioPharm
Keele, UK · Sodertalje, SE
 88.0 100.0 0 insp · 3 GMP — 0 programs
9
AE
Aldevron
Fargo, ND
 85.3 100.0 1 insp · 0 GMP — 0 programs
10
FD
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
 83.5 100.0 0 insp · 23 GMP Expanding 0 programs
How we score CDMOs →

What to evaluate in a mRNA / LNP CDMO

IVT mRNA synthesis
Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.
LNP formulation
LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.
Plasmid / starting material
mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.
Cold chain & stability
mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.

mRNA / LNP CDMOs — Frequently Asked Questions

Who are the top mRNA / LNP CDMOs?
By CDMO Signal's independent Signal Score, the top-ranked mRNA / LNP CDMOs include Pfizer CentreOne, BioNTech (Mfg Services), Moderna (Contract Mfg). See the full ranked table above — scored on FDA, clinical, financial, and capacity data.
How many mRNA / LNP CDMOs have FDA inspection records?
CDMO Signal tracks 6 mRNA / LNP CDMOs with FDA inspection records and 72 EMA/MHRA GMP certificates across the group.
What should I look for in an mRNA / LNP CDMO?
Look for proven IVT mRNA synthesis at your scale, LNP formulation via microfluidics, a clear template/plasmid supply strategy, cold-chain capability, and a clean FDA and EMA/MHRA record.
Do mRNA CDMOs also make the LNP and plasmid?
Capabilities vary. Some CDMOs offer end-to-end IVT mRNA, LNP formulation, and GMP plasmid; others specialize in one step and coordinate partners. Check each profile's modality coverage above.
Related modalities
Plasmid DNA CDMOs Lentiviral Vector CDMOs AAV / Gene Therapy CDMOs
Other Modalities
AAV CAR-T Lentiviral Cell Therapy Plasmid DNA Biologics Oligo/ASO Adenoviral Gene Editing Exosome Recombinant Proteins ADC Gene Therapy Cell & Gene Therapy